Transcat (TRNS) Financials

$91.32 -0.31 (-0.34%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$91.26 -0.06 (-0.07%)

As of 05/23/2025 04:04 PM Eastern

Annual Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/30/2024	3/25/2023	3/26/2022
Net Income / (Loss) Attributable to Common Shareholders	14	11	11
Consolidated Net Income / (Loss)	14	11	11
Net Income / (Loss) Continuing Operations	14	11	11
Total Pre-Tax Income	18	13	13
Total Operating Income	20	16	14
Total Gross Profit	84	68	58
Total Revenue	259	231	205
Operating Revenue	259	231	205
Total Cost of Revenue	176	162	147
Operating Cost of Revenue	176	162	147
Total Operating Expenses	64	52	44
Selling, General & Admin Expense	35	27	24
Marketing Expense	29	25	21
Total Other Income / (Expense), net	-1.34	-2.76	-0.95
Interest Expense	1.84	2.42	0.81
Interest & Investment Income	0.81	0.00	0.00
Other Income / (Expense), net	-0.32	-0.34	-0.14
Income Tax Expense	4.79	2.80	1.81
Basic Earnings per Share	$1.66	$1.42	$1.52
Weighted Average Basic Shares Outstanding	8.24M	7.55M	7.50M
Diluted Earnings per Share	$1.63	$1.40	$1.50
Weighted Average Diluted Shares Outstanding	8.35M	7.65M	7.59M
Weighted Average Basic & Diluted Shares Outstanding	9.13M	7.64M	7.55M

This table shows Transcat's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/23/2023	9/23/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022	6/25/2022
Net Income / (Loss) Attributable to Common Shareholders	2.36	3.29	4.41	6.89	3.35	0.46	2.95	3.66	1.60	2.36	3.07
Consolidated Net Income / (Loss)	2.36	3.29	4.41	6.89	3.35	0.46	2.95	3.66	1.60	2.36	3.07
Net Income / (Loss) Continuing Operations	2.36	3.29	4.41	6.89	3.35	0.46	2.95	3.66	1.60	2.36	3.07
Total Pre-Tax Income	3.13	3.71	5.23	9.60	4.27	0.80	3.76	4.83	2.12	3.09	3.45
Total Operating Income	2.10	3.74	5.10	9.20	4.29	1.64	4.64	5.86	3.16	3.63	3.60
Total Gross Profit	20	21	23	24	21	20	19	19	16	17	16
Total Revenue	67	68	67	71	65	63	61	62	57	56	55
Operating Revenue	67	68	67	71	65	63	61	62	57	56	55
Total Cost of Revenue	47	47	44	47	44	43	42	43	41	40	39
Operating Cost of Revenue	47	47	44	47	44	43	42	43	41	40	39
Total Operating Expenses	18	17	18	15	17	18	14	13	13	13	12
Selling, General & Admin Expense	9.46	9.29	9.76	6.97	9.12	12	7.60	6.85	6.64	7.24	6.61
Marketing Expense	8.12	8.18	7.80	7.87	7.52	6.86	6.47	6.45	6.60	5.90	5.82
Total Other Income / (Expense), net	1.03	-0.02	0.13	0.40	-0.02	-0.84	-0.88	-1.03	-1.04	-0.54	-0.16
Interest Expense	0.20	0.08	0.05	-	0.08	0.89	0.81	-	0.73	-	-
Interest & Investment Income	0.22	0.29	0.31	-	0.35	0.00	0.00	-	0.01	-	-
Other Income / (Expense), net	1.01	-0.23	-0.13	0.88	-0.29	0.05	-0.06	0.66	-0.31	-0.54	-0.16
Income Tax Expense	0.77	0.43	0.82	2.71	0.92	0.34	0.81	1.17	0.52	0.73	0.38
Basic Earnings per Share	$0.26	$0.36	$0.49	$0.82	$0.39	$0.06	$0.39	$0.49	$0.21	$0.31	$0.41
Weighted Average Basic Shares Outstanding	9.23M	9.16M	9.06M	8.24M	8.62M	7.82M	7.62M	7.55M	7.56M	7.55M	7.54M
Diluted Earnings per Share	$0.25	$0.35	$0.48	$0.81	$0.38	$0.06	$0.38	$0.48	$0.21	$0.31	$0.40
Weighted Average Diluted Shares Outstanding	9.33M	9.28M	9.20M	8.35M	8.75M	7.95M	7.76M	7.65M	7.67M	7.65M	7.63M
Weighted Average Basic & Diluted Shares Outstanding	9.31M	9.20M	9.15M	9.13M	8.83M	8.83M	7.69M	7.64M	7.56M	7.56M	7.55M

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/30/2024	3/25/2023	3/26/2022
Net Change in Cash & Equivalents	18	0.14	0.84
Net Cash From Operating Activities	33	17	18
Net Cash From Continuing Operating Activities	33	17	18
Net Income / (Loss) Continuing Operations	14	11	11
Consolidated Net Income / (Loss)	14	11	11
Depreciation Expense	14	11	9.57
Non-Cash Adjustments To Reconcile Net Income	4.97	3.54	2.45
Changes in Operating Assets and Liabilities, net	0.45	-8.23	-5.78
Net Cash From Investing Activities	-42	-19	-40
Net Cash From Continuing Investing Activities	-42	-19	-40
Purchase of Property, Plant & Equipment	-13	-9.41	-10
Acquisitions	-13	-9.11	-30
Purchase of Investments	-16	0.00	0.00
Sale of Property, Plant & Equipment	0.00	0.01	0.11
Net Cash From Financing Activities	27	0.88	24
Net Cash From Continuing Financing Activities	27	0.88	24
Repayment of Debt	-2.25	-2.12	-2.11
Repurchase of Common Equity	-4.91	-0.45	-6.68
Issuance of Debt	-43	2.79	31
Issuance of Common Equity	77	0.66	1.49
Other Net Changes in Cash	-0.23	0.82	-0.63
Cash Interest Paid	1.24	2.26	0.78
Cash Income Taxes Paid	3.10	1.12	3.90

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/23/2023	9/23/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022	6/25/2022
Net Change in Cash & Equivalents	-19	1.16	3.01	-16	34	-0.90	0.62	-0.06	0.68	0.47	-0.95
Net Cash From Operating Activities	13	6.84	8.92	5.73	11	8.44	7.54	2.98	8.74	3.19	2.04
Net Cash From Continuing Operating Activities	13	6.73	8.92	5.73	11	8.44	7.54	2.98	8.74	3.19	2.04
Net Income / (Loss) Continuing Operations	2.36	3.29	4.41	6.89	3.35	0.46	2.95	3.66	1.60	2.36	3.07
Consolidated Net Income / (Loss)	2.36	3.29	4.41	6.89	3.35	0.46	2.95	3.66	1.60	2.36	3.07
Depreciation Expense	4.43	4.40	4.11	3.70	3.76	3.29	2.79	2.71	2.82	2.78	2.64
Non-Cash Adjustments To Reconcile Net Income	-0.37	1.07	0.60	1.23	1.21	1.45	1.08	0.55	0.92	1.14	0.93
Changes in Operating Assets and Liabilities, net	6.29	-2.03	-0.20	-6.10	2.59	3.24	0.72	-3.94	3.39	-3.09	-4.60
Net Cash From Investing Activities	-72	-3.86	-4.09	-20	-3.71	-13	-5.64	-3.07	-6.64	-2.37	-6.43
Net Cash From Continuing Investing Activities	-72	-3.86	-4.09	-20	-3.71	-13	-5.64	-3.07	-6.64	-2.37	-6.43
Purchase of Property, Plant & Equipment	-2.87	-3.96	-3.67	-4.18	-3.66	-2.68	-2.77	-2.27	-2.38	-2.37	-2.40
Acquisitions	-70	0.10	-16	0.07	-0.05	-10	-2.87	-0.80	-4.27	-	-4.04
Net Cash From Financing Activities	40	-1.41	-1.94	-1.68	27	3.17	-0.86	0.09	-1.51	-0.82	3.11
Net Cash From Continuing Financing Activities	40	-1.41	-1.94	-1.68	27	3.17	-0.86	0.09	-1.51	-0.82	3.11
Repayment of Debt	39	-0.58	-0.58	-0.57	-43	-0.56	-0.55	-0.55	-0.54	-0.54	-0.49
Repurchase of Common Equity	-0.18	-1.41	-1.62	-2.66	-	-1.95	-0.30	-0.01	-	-	-0.44
Issuance of Common Equity	0.93	0.58	0.26	1.55	75	0.19	0.20	0.16	0.14	0.14	0.22
Effect of Exchange Rate Changes	0.58	-	-	-	-	-	-	-	-	-	0.32
Cash Income Taxes Paid	1.33	5.47	0.06	1.22	0.79	0.99	0.11	0.16	0.47	0.37	0.12

This table presents Transcat's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	3/30/2024	3/25/2023	3/26/2022
Total Assets	288	196	178
Total Current Assets	105	68	60
Cash & Equivalents	20	1.53	1.40
Short-Term Investments	16	0.00	-
Accounts Receivable	48	45	40
Inventories, net	17	17	13
Prepaid Expenses	4.28	3.94	5.30
Plant, Property, & Equipment, net	39	29	26
Total Noncurrent Assets	143	99	92
Goodwill	106	69	65
Intangible Assets	20	14	15
Other Noncurrent Operating Assets	18	16	12
Total Liabilities & Shareholders' Equity	288	196	178
Total Liabilities	62	96	92
Total Current Liabilities	33	28	28
Short-Term Debt	2.34	2.25	2.16
Accounts Payable	11	16	14
Accrued Expenses	20	10	11
Total Noncurrent Liabilities	29	68	64
Long-Term Debt	1.82	47	46
Noncurrent Deferred & Payable Income Tax Liabilities	9.29	6.54	6.72
Other Noncurrent Operating Liabilities	18	14	11
Total Equity & Noncontrolling Interests	225	100	86
Total Preferred & Common Equity	225	100	86
Total Common Equity	225	100	86
Common Stock	146	32	28
Retained Earnings	80	69	59
Accumulated Other Comprehensive Income / (Loss)	-0.95	-1.20	-0.23

This table presents Transcat's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	12/28/2024	9/28/2024	6/29/2024	12/23/2023	9/23/2023	6/24/2023	12/24/2022	9/24/2022	6/25/2022
Total Assets	386	324	324	281	248	203	188	187	182
Total Current Assets	77	95	94	99	65	64	61	63	59
Cash & Equivalents	4.64	24	23	35	1.25	2.15	1.59	0.91	0.44
Short-Term Investments	0.00	0.00	0.00	-	-	-	-	-	-
Accounts Receivable	52	50	48	44	45	43	38	41	38
Inventories, net	14	16	18	16	16	15	17	17	15
Prepaid Expenses	5.77	6.24	5.07	3.30	3.53	3.39	4.14	4.42	4.85
Plant, Property, & Equipment, net	50	47	46	37	36	30	28	28	27
Total Noncurrent Assets	259	181	183	145	147	110	99	96	96
Goodwill	177	138	138	106	106	77	69	66	67
Intangible Assets	58	24	26	21	23	15	15	15	16
Other Noncurrent Operating Assets	25	18	19	18	18	17	16	15	13
Total Liabilities & Shareholders' Equity	386	324	324	281	248	203	188	187	182
Total Liabilities	105	55	61	63	110	93	93	94	92
Total Current Liabilities	32	27	32	29	28	24	25	25	24
Short-Term Debt	2.41	2.39	2.36	2.32	2.29	2.27	2.23	2.21	2.18
Accounts Payable	16	13	13	11	13	12	14	14	-
Accrued Expenses	13	11	13	16	13	9.29	9.01	9.09	-
Total Noncurrent Liabilities	73	28	30	33	82	69	68	70	69
Long-Term Debt	39	0.61	1.22	2.41	51	46	47	49	50
Noncurrent Deferred & Payable Income Tax Liabilities	9.26	9.30	9.29	11	11	7.18	6.67	6.67	6.70
Other Noncurrent Operating Liabilities	24	18	19	20	20	16	14	14	12
Total Equity & Noncontrolling Interests	281	269	262	218	138	111	95	92	90
Total Preferred & Common Equity	281	269	262	218	138	111	95	92	90
Total Common Equity	281	269	262	218	138	111	95	92	90
Common Stock	195	184	180	145	68	40	31	30	29
Retained Earnings	88	86	84	74	71	72	66	64	62
Accumulated Other Comprehensive Income / (Loss)	-1.88	-0.72	-1.10	-0.69	-1.06	-0.72	-1.12	-1.52	-0.69

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric	2024	2023	2022
Period end date	3/30/2024	3/25/2023	3/26/2022
Growth Metrics	-	-	-
Revenue Growth	12.54%	12.50%	18.24%
EBITDA Growth	22.90%	13.97%	34.19%
EBIT Growth	22.40%	13.60%	40.25%
NOPAT Growth	13.70%	5.52%	41.19%
Net Income Growth	27.69%	-6.08%	46.07%
EPS Growth	16.43%	-6.67%	45.63%
Operating Cash Flow Growth	92.41%	-3.79%	-25.47%
Free Cash Flow Firm Growth	-2,814.24%	94.17%	-636.89%
Invested Capital Growth	31.88%	10.50%	30.57%
Revenue Q/Q Growth	3.53%	2.76%	3.60%
EBITDA Q/Q Growth	16.02%	6.37%	6.49%
EBIT Q/Q Growth	22.43%	10.91%	5.68%
NOPAT Q/Q Growth	16.86%	9.73%	-0.94%
Net Income Q/Q Growth	31.03%	6.05%	-1.39%
EPS Q/Q Growth	25.38%	6.06%	-1.32%
Operating Cash Flow Q/Q Growth	9.21%	-11.78%	-13.51%
Free Cash Flow Firm Q/Q Growth	0.97%	89.19%	-49.30%
Invested Capital Q/Q Growth	3.27%	3.05%	10.22%
Profitability Metrics	-	-	-
Gross Margin	32.30%	29.65%	28.51%
EBITDA Margin	12.72%	11.65%	11.50%
Operating Margin	7.62%	7.05%	6.90%
EBIT Margin	7.50%	6.90%	6.83%
Profit (Net Income) Margin	5.26%	4.64%	5.55%
Tax Burden Percent	74.01%	79.25%	86.28%
Interest Burden Percent	94.72%	84.80%	94.21%
Effective Tax Rate	25.99%	20.75%	13.72%
Return on Invested Capital (ROIC)	8.58%	9.18%	10.37%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.42%	4.56%	8.15%
Return on Net Nonoperating Assets (RNNOA)	-0.17%	2.32%	3.74%
Return on Equity (ROE)	8.40%	11.50%	14.11%
Cash Return on Invested Capital (CROIC)	-18.92%	-0.79%	-16.15%
Operating Return on Assets (OROA)	8.06%	8.52%	9.04%
Return on Assets (ROA)	5.65%	5.72%	7.34%
Return on Common Equity (ROCE)	8.40%	11.50%	14.11%
Return on Equity Simple (ROE_SIMPLE)	6.06%	10.73%	13.21%
Net Operating Profit after Tax (NOPAT)	15	13	12
NOPAT Margin	5.64%	5.58%	5.95%
Net Nonoperating Expense Percent (NNEP)	11.99%	4.62%	2.22%
Cost of Revenue to Revenue	67.70%	70.35%	71.49%
SG&A Expenses to Revenue	13.61%	11.86%	11.54%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	24.67%	22.60%	21.61%
Earnings before Interest and Taxes (EBIT)	19	16	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	33	27	24
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	4.37	6.59	6.48
Price to Tangible Book Value (P/TBV)	9.88	39.84	87.08
Price to Revenue (P/Rev)	3.79	2.85	2.72
Price to Earnings (P/E)	72.09	61.40	49.05
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	1.39%	1.63%	2.04%
Enterprise Value to Invested Capital (EV/IC)	4.91	4.78	4.54
Enterprise Value to Revenue (EV/Rev)	3.67	3.05	2.95
Enterprise Value to EBITDA (EV/EBITDA)	28.86	26.21	25.68
Enterprise Value to EBIT (EV/EBIT)	48.95	44.26	43.23
Enterprise Value to NOPAT (EV/NOPAT)	65.08	54.66	49.60
Enterprise Value to Operating Cash Flow (EV/OCF)	29.21	41.52	34.35
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.02	0.49	0.56
Long-Term Debt to Equity	0.01	0.47	0.54
Financial Leverage	0.05	0.51	0.46
Leverage Ratio	1.49	2.01	1.92
Compound Leverage Factor	1.41	1.70	1.81
Debt to Total Capital	1.81%	33.02%	35.99%
Short-Term Debt to Total Capital	1.02%	1.51%	1.61%
Long-Term Debt to Total Capital	0.79%	31.51%	34.38%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	98.19%	66.98%	64.01%
Debt to EBITDA	0.13	1.83	2.06
Net Debt to EBITDA	-0.94	1.77	2.00
Long-Term Debt to EBITDA	0.06	1.75	1.96
Debt to NOPAT	0.28	3.81	3.97
Net Debt to NOPAT	-2.12	3.70	3.86
Long-Term Debt to NOPAT	0.12	3.64	3.79
Altman Z-Score	11.28	6.28	5.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	3.14	2.39	2.15
Quick Ratio	2.49	1.65	1.50
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-32	-1.11	-19
Operating Cash Flow to CapEx	245.60%	180.25%	175.43%
Free Cash Flow to Firm to Interest Expense	-17.60	-0.46	-23.45
Operating Cash Flow to Interest Expense	17.77	7.01	21.75
Operating Cash Flow Less CapEx to Interest Expense	10.54	3.12	9.35
Efficiency Ratios	-	-	-
Asset Turnover	1.07	1.23	1.32
Accounts Receivable Turnover	5.55	5.39	5.49
Inventory Turnover	10.23	10.95	12.04
Fixed Asset Turnover	7.63	8.31	8.43
Accounts Payable Turnover	12.84	10.80	11.08
Days Sales Outstanding (DSO)	65.75	67.67	66.49
Days Inventory Outstanding (DIO)	35.68	33.35	30.33
Days Payable Outstanding (DPO)	28.43	33.80	32.94
Cash Conversion Cycle (CCC)	73.01	67.23	63.88
Capital & Investment Metrics	-	-	-
Invested Capital	194	147	133
Invested Capital Turnover	1.52	1.64	1.74
Increase / (Decrease) in Invested Capital	47	14	31
Enterprise Value (EV)	953	704	605
Market Capitalization	984	656	558
Book Value per Share	$25.50	$13.18	$11.46
Tangible Book Value per Share	$11.28	$2.18	$0.85
Total Capital	229	149	135
Total Debt	4.16	49	48
Total Long-Term Debt	1.82	47	46
Net Debt	-31	48	47
Capital Expenditures (CapEx)	13	9.40	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	40	33
Debt-free Net Working Capital (DFNWC)	74	42	34
Net Working Capital (NWC)	72	39	32
Net Nonoperating Expense (NNE)	0.99	2.19	0.82
Net Nonoperating Obligations (NNO)	-31	48	47
Total Depreciation and Amortization (D&A)	14	11	9.57
Debt-free, Cash-free Net Working Capital to Revenue	14.96%	17.35%	15.98%
Debt-free Net Working Capital to Revenue	28.52%	18.01%	16.66%
Net Working Capital to Revenue	27.62%	17.04%	15.61%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.66	$1.42	$1.52
Adjusted Weighted Average Basic Shares Outstanding	8.24M	7.55M	7.50M
Adjusted Diluted Earnings per Share	$1.63	$1.40	$1.50
Adjusted Weighted Average Diluted Shares Outstanding	8.35M	7.65M	7.59M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.13M	7.64M	7.55M
Normalized Net Operating Profit after Tax (NOPAT)	15	13	12
Normalized NOPAT Margin	5.64%	5.58%	5.95%
Pre Tax Income Margin	7.11%	5.85%	6.44%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	10.61	6.58	17.28
NOPAT to Interest Expense	7.98	5.33	15.06
EBIT Less CapEx to Interest Expense	3.37	2.69	4.89
NOPAT Less CapEx to Interest Expense	0.74	1.44	2.67
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	35.95%	4.18%	58.73%

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/23/2023	9/23/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022	6/25/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.44%	8.00%	10.08%	14.25%	13.53%	11.28%	10.86%	11.07%	12.77%	12.01%	14.38%
EBITDA Growth	-2.97%	58.69%	23.28%	49.38%	36.91%	-15.12%	20.97%	21.10%	13.64%	7.28%	11.03%
EBIT Growth	-22.37%	107.03%	8.57%	54.72%	40.53%	-45.23%	32.71%	31.58%	28.09%	-7.18%	-1.32%
NOPAT Growth	-53.00%	250.76%	18.20%	48.79%	41.18%	-65.94%	13.28%	33.61%	37.93%	-14.65%	-17.54%
Net Income Growth	-29.60%	614.35%	49.47%	88.35%	109.12%	-80.48%	-4.00%	20.01%	-1.72%	-21.82%	-16.70%
EPS Growth	-34.21%	483.33%	26.32%	68.75%	80.95%	-80.65%	-5.00%	20.00%	0.00%	-22.50%	-18.37%
Operating Cash Flow Growth	15.40%	-18.98%	18.42%	92.44%	24.91%	164.29%	268.87%	-43.21%	79.25%	-41.40%	-0.58%
Free Cash Flow Firm Growth	-208.31%	-15.30%	-533.56%	-322.45%	-113.10%	-158.62%	66.39%	65.75%	15.92%	30.27%	-4,566.56%
Invested Capital Growth	69.34%	30.29%	54.98%	31.88%	31.59%	33.79%	11.81%	10.50%	18.19%	17.31%	42.28%
Revenue Q/Q Growth	-1.58%	1.68%	-5.93%	8.82%	3.76%	3.64%	-2.37%	8.13%	1.71%	3.25%	-2.18%
EBITDA Q/Q Growth	-4.63%	-12.97%	-34.13%	77.47%	55.98%	-32.39%	-20.19%	62.65%	-3.29%	-3.65%	-20.10%
EBIT Q/Q Growth	-11.25%	-29.49%	-50.73%	151.76%	136.70%	-63.02%	-29.78%	128.67%	-7.74%	-10.41%	-30.39%
NOPAT Q/Q Growth	-52.14%	-23.11%	-34.89%	96.17%	257.19%	-74.09%	-18.04%	86.14%	-13.83%	-13.84%	-3.33%
Net Income Q/Q Growth	-28.27%	-25.45%	-36.02%	105.79%	627.83%	-84.40%	-19.38%	128.48%	-32.07%	-23.27%	0.79%
EPS Q/Q Growth	-28.57%	-27.08%	-40.74%	113.16%	533.33%	-84.21%	-20.83%	128.57%	-32.26%	-22.50%	0.00%
Operating Cash Flow Q/Q Growth	84.32%	-23.41%	55.82%	-47.54%	29.41%	11.94%	153.23%	-65.95%	173.81%	56.24%	-61.01%
Free Cash Flow Firm Q/Q Growth	-136.99%	33.72%	-103.29%	3.45%	11.37%	-264.19%	-35.55%	51.30%	-7.57%	52.66%	-38.10%
Invested Capital Q/Q Growth	28.40%	1.94%	25.27%	3.27%	-1.21%	21.26%	6.60%	3.05%	0.44%	1.34%	5.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.48%	31.27%	33.96%	33.89%	32.13%	32.04%	30.88%	30.85%	28.57%	29.71%	29.34%
EBITDA Margin	11.29%	11.65%	13.61%	19.44%	11.92%	7.93%	12.16%	14.87%	9.88%	10.40%	11.14%
Operating Margin	3.15%	5.51%	7.64%	12.98%	6.59%	2.62%	7.66%	9.43%	5.51%	6.42%	6.59%
EBIT Margin	4.66%	5.16%	7.45%	14.22%	6.15%	2.69%	7.55%	10.50%	4.97%	5.47%	6.31%
Profit (Net Income) Margin	3.53%	4.84%	6.61%	9.72%	5.14%	0.73%	4.87%	5.89%	2.79%	4.18%	5.62%
Tax Burden Percent	75.33%	88.50%	84.32%	71.74%	78.39%	57.36%	78.39%	75.80%	75.38%	76.30%	89.10%
Interest Burden Percent	100.64%	105.99%	105.23%	95.25%	106.64%	47.40%	82.21%	74.05%	74.53%	100.00%	100.00%
Effective Tax Rate	24.67%	11.50%	15.68%	28.26%	21.61%	42.64%	21.61%	24.20%	24.62%	23.70%	10.90%
Return on Invested Capital (ROIC)	2.55%	6.02%	8.56%	14.16%	7.83%	2.19%	9.55%	11.76%	7.07%	8.11%	10.41%
ROIC Less NNEP Spread (ROIC-NNEP)	25.39%	5.89%	9.36%	17.62%	7.62%	1.25%	8.13%	10.11%	5.24%	7.20%	10.03%
Return on Net Nonoperating Assets (RNNOA)	0.34%	0.45%	0.68%	0.90%	0.42%	0.55%	3.94%	5.15%	2.51%	3.76%	4.39%
Return on Equity (ROE)	2.89%	6.47%	9.24%	15.05%	8.24%	2.74%	13.49%	16.91%	9.58%	11.87%	14.80%
Cash Return on Invested Capital (CROIC)	-45.27%	-18.30%	-35.45%	-18.92%	-19.71%	-21.98%	-2.25%	-0.79%	-7.77%	-7.55%	-25.27%
Operating Return on Assets (OROA)	3.80%	4.89%	7.51%	15.27%	6.56%	3.01%	9.27%	12.96%	6.36%	6.91%	8.53%
Return on Assets (ROA)	2.88%	4.59%	6.66%	10.43%	5.48%	0.82%	5.97%	7.28%	3.58%	5.27%	7.60%
Return on Common Equity (ROCE)	2.89%	6.47%	9.24%	15.05%	8.24%	2.74%	13.49%	16.91%	9.58%	11.87%	14.80%
Return on Equity Simple (ROE_SIMPLE)	6.03%	6.67%	5.76%	0.00%	4.77%	6.27%	9.54%	0.00%	10.58%	10.95%	12.02%
Net Operating Profit after Tax (NOPAT)	1.58	3.31	4.30	6.60	3.37	0.94	3.64	4.44	2.38	2.77	3.21
NOPAT Margin	2.37%	4.87%	6.45%	9.31%	5.17%	1.50%	6.00%	7.15%	4.15%	4.90%	5.87%
Net Nonoperating Expense Percent (NNEP)	-22.84%	0.12%	-0.80%	-3.47%	0.21%	0.95%	1.42%	1.65%	1.83%	0.91%	0.38%
Return On Investment Capital (ROIC_SIMPLE)	0.49%	-	-	-	1.51%	-	-	-	-	-	-
Cost of Revenue to Revenue	70.52%	68.73%	66.04%	66.11%	67.87%	67.96%	69.12%	69.15%	71.43%	70.29%	70.66%
SG&A Expenses to Revenue	14.17%	13.70%	14.62%	9.82%	14.00%	18.51%	12.54%	11.03%	11.57%	12.83%	12.10%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.33%	25.76%	26.32%	20.91%	25.54%	29.43%	23.22%	21.42%	23.06%	23.28%	22.75%
Earnings before Interest and Taxes (EBIT)	3.11	3.50	4.97	10	4.01	1.69	4.58	6.52	2.85	3.09	3.45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	7.54	7.90	9.08	14	7.77	4.98	7.37	9.23	5.67	5.87	6.09
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.47	4.13	4.17	4.37	4.35	5.28	6.02	6.59	5.55	5.56	5.19
Price to Tangible Book Value (P/TBV)	20.85	10.46	11.17	9.88	10.41	83.67	35.99	39.84	45.54	45.29	67.60
Price to Revenue (P/Rev)	3.58	4.11	4.12	3.79	3.79	3.01	2.82	2.85	2.36	2.35	2.19
Price to Earnings (P/E)	57.57	61.96	72.36	72.09	91.23	84.27	63.11	61.40	52.48	50.77	43.15
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.74%	1.61%	1.38%	1.39%	1.10%	1.19%	1.58%	1.63%	1.91%	1.97%	2.32%
Enterprise Value to Invested Capital (EV/IC)	3.18	4.40	4.42	4.91	4.89	4.11	4.54	4.78	4.04	3.96	3.67
Enterprise Value to Revenue (EV/Rev)	3.72	4.03	4.04	3.67	3.67	3.22	3.01	3.05	2.57	2.58	2.43
Enterprise Value to EBITDA (EV/EBITDA)	27.06	28.96	30.93	28.86	31.34	28.72	25.34	26.21	22.83	22.91	21.34
Enterprise Value to EBIT (EV/EBIT)	48.74	50.32	54.09	48.95	54.78	50.05	41.86	44.26	40.20	41.05	36.96
Enterprise Value to NOPAT (EV/NOPAT)	64.32	62.12	69.92	65.08	73.41	67.93	53.89	54.66	49.13	50.97	44.80
Enterprise Value to Operating Cash Flow (EV/OCF)	29.71	33.65	31.59	29.21	30.79	28.26	31.77	41.52	30.00	36.67	29.30
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.01	0.01	0.02	0.02	0.39	0.44	0.49	0.52	0.55	0.58
Long-Term Debt to Equity	0.14	0.00	0.00	0.01	0.01	0.37	0.42	0.47	0.49	0.53	0.55
Financial Leverage	0.01	0.08	0.07	0.05	0.05	0.44	0.48	0.51	0.48	0.52	0.44
Leverage Ratio	1.34	1.40	1.41	1.49	1.50	1.89	1.92	2.01	1.96	1.99	1.88
Compound Leverage Factor	1.34	1.49	1.49	1.42	1.60	0.89	1.58	1.49	1.46	1.99	1.88
Debt to Total Capital	12.97%	1.10%	1.35%	1.81%	2.12%	27.82%	30.40%	33.02%	34.04%	35.50%	36.64%
Short-Term Debt to Total Capital	0.75%	0.88%	0.89%	1.02%	1.04%	1.20%	1.43%	1.51%	1.54%	1.54%	1.54%
Long-Term Debt to Total Capital	12.23%	0.23%	0.46%	0.79%	1.08%	26.63%	28.97%	31.51%	32.50%	33.96%	35.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.03%	98.90%	98.65%	98.19%	97.88%	72.18%	69.60%	66.98%	65.96%	64.50%	63.36%
Debt to EBITDA	1.12	0.08	0.10	0.13	0.16	1.96	1.72	1.83	1.95	2.07	2.14
Net Debt to EBITDA	1.00	-0.55	-0.55	-0.94	-1.04	1.91	1.64	1.77	1.88	2.03	2.12
Long-Term Debt to EBITDA	1.06	0.02	0.04	0.06	0.08	1.87	1.64	1.75	1.86	1.98	2.05
Debt to NOPAT	2.66	0.17	0.23	0.28	0.38	4.63	3.66	3.81	4.19	4.60	4.50
Net Debt to NOPAT	2.37	-1.19	-1.24	-2.12	-2.43	4.52	3.49	3.70	4.05	4.52	4.46
Long-Term Debt to NOPAT	2.51	0.03	0.08	0.12	0.19	4.43	3.48	3.64	4.00	4.40	4.31
Altman Z-Score	6.77	13.66	12.15	11.17	10.71	5.57	6.29	6.12	5.36	5.20	4.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.42	3.59	2.96	3.14	3.37	2.32	2.68	2.39	2.42	2.52	2.48
Quick Ratio	1.80	2.77	2.23	2.49	2.70	1.64	1.90	1.65	1.58	1.66	1.62
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-129	-54	-82	-40	-42	-47	-13	-9.55	-20	-18	-38
Operating Cash Flow to CapEx	439.11%	172.64%	242.90%	136.98%	298.69%	315.13%	272.35%	131.39%	367.69%	134.51%	85.52%
Free Cash Flow to Firm to Interest Expense	-647.10	-714.94	-1,576.55	0.00	-515.64	-52.95	-15.90	0.00	-26.81	0.00	0.00
Operating Cash Flow to Interest Expense	63.31	89.93	171.62	0.00	134.78	9.48	9.26	0.00	11.96	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	48.89	37.84	100.96	0.00	89.65	6.47	5.86	0.00	8.70	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.95	1.01	1.07	1.07	1.12	1.23	1.23	1.28	1.26	1.35
Accounts Receivable Turnover	5.64	5.74	5.82	5.55	6.10	5.70	5.85	5.39	6.11	5.63	5.91
Inventory Turnover	12.32	11.64	10.68	10.23	10.39	10.38	10.99	10.95	10.31	11.48	11.35
Fixed Asset Turnover	6.21	6.51	6.98	7.63	7.65	7.66	8.24	8.31	8.61	8.58	8.58
Accounts Payable Turnover	13.41	14.22	14.44	12.84	13.63	12.90	0.00	10.80	11.82	12.59	0.00
Days Sales Outstanding (DSO)	64.69	63.58	62.72	65.75	59.86	64.05	62.44	67.67	59.71	64.86	61.80
Days Inventory Outstanding (DIO)	29.63	31.36	34.18	35.68	35.14	35.15	33.21	33.35	35.41	31.80	32.15
Days Payable Outstanding (DPO)	27.22	25.67	25.29	28.43	26.78	28.29	0.00	33.80	30.87	28.99	0.00
Cash Conversion Cycle (CCC)	67.09	69.27	71.62	73.01	68.21	70.91	95.65	67.23	64.25	67.68	93.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	318	248	243	194	188	190	157	147	143	142	140
Invested Capital Turnover	1.08	1.24	1.33	1.52	1.52	1.46	1.59	1.64	1.70	1.65	1.77
Increase / (Decrease) in Invested Capital	130	58	86	47	45	48	17	14	22	21	42
Enterprise Value (EV)	1,012	1,090	1,074	953	920	782	713	704	577	563	516
Market Capitalization	975	1,111	1,093	984	950	730	667	656	529	513	464
Book Value per Share	$30.55	$29.39	$28.72	$25.50	$24.75	$17.98	$14.49	$13.18	$12.61	$12.23	$11.87
Tangible Book Value per Share	$5.09	$11.62	$10.72	$11.28	$10.35	$1.14	$2.42	$2.18	$1.54	$1.50	$0.91
Total Capital	323	272	266	229	223	192	159	149	144	143	141
Total Debt	42	3.00	3.58	4.16	4.73	53	48	49	49	51	52
Total Long-Term Debt	39	0.61	1.22	1.82	2.41	51	46	47	47	49	50
Net Debt	37	-21	-19	-31	-30	52	46	48	48	50	51
Capital Expenditures (CapEx)	2.87	3.96	3.67	4.18	3.66	2.68	2.77	2.27	2.38	2.37	2.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	43	47	42	39	37	38	40	40	36	39	37
Debt-free Net Working Capital (DFNWC)	47	71	65	74	72	39	42	42	38	40	37
Net Working Capital (NWC)	45	69	62	72	69	37	40	39	36	38	35
Net Nonoperating Expense (NNE)	-0.78	0.02	-0.11	-0.29	0.02	0.48	0.69	0.78	0.78	0.41	0.14
Net Nonoperating Obligations (NNO)	37	-21	-19	-31	-30	52	46	48	48	50	51
Total Depreciation and Amortization (D&A)	4.43	4.40	4.11	3.70	3.76	3.29	2.79	2.71	2.82	2.78	2.64
Debt-free, Cash-free Net Working Capital to Revenue	15.67%	17.45%	15.87%	14.96%	14.59%	15.69%	16.91%	17.35%	16.15%	17.91%	17.37%
Debt-free Net Working Capital to Revenue	17.37%	26.25%	24.40%	28.52%	28.63%	16.20%	17.82%	18.01%	16.86%	18.33%	17.58%
Net Working Capital to Revenue	16.49%	25.37%	23.51%	27.62%	27.71%	15.26%	16.86%	17.04%	15.87%	17.31%	16.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.26	$0.36	$0.49	$0.82	$0.39	$0.06	$0.39	$0.49	$0.21	$0.31	$0.41
Adjusted Weighted Average Basic Shares Outstanding	9.23M	9.16M	9.06M	8.24M	8.62M	7.82M	7.62M	7.55M	7.56M	7.55M	7.54M
Adjusted Diluted Earnings per Share	$0.25	$0.35	$0.48	$0.81	$0.38	$0.06	$0.38	$0.48	$0.21	$0.31	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	9.33M	9.28M	9.20M	8.35M	8.75M	7.95M	7.76M	7.65M	7.67M	7.65M	7.63M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.31M	9.20M	9.15M	9.13M	8.83M	8.83M	7.69M	7.64M	7.56M	7.56M	7.55M
Normalized Net Operating Profit after Tax (NOPAT)	1.58	3.31	4.30	6.60	3.37	0.94	3.64	4.44	2.38	2.77	3.21
Normalized NOPAT Margin	2.37%	4.87%	6.45%	9.31%	5.17%	1.50%	6.00%	7.15%	4.15%	4.90%	5.87%
Pre Tax Income Margin	4.69%	5.47%	7.84%	13.54%	6.55%	1.28%	6.21%	7.78%	3.70%	5.47%	6.31%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.62	46.09	95.54	0.00	49.44	1.90	5.62	0.00	3.90	0.00	0.00
NOPAT to Interest Expense	7.95	43.49	82.68	0.00	41.56	1.06	4.47	0.00	3.26	0.00	0.00
EBIT Less CapEx to Interest Expense	1.21	-6.00	24.88	0.00	4.32	-1.11	2.22	0.00	0.65	0.00	0.00
NOPAT Less CapEx to Interest Expense	-6.47	-8.60	12.02	0.00	-3.57	-1.95	1.07	0.00	0.01	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	34.63%	31.70%	41.20%	35.95%	21.67%	26.04%	2.94%	4.18%	14.60%	14.56%	34.77%

Frequently Asked Questions About Transcat's Financials

When does Transcat's financial year end?

According to the most recent income statement we have on file, Transcat's fiscal year ends in March. Their fiscal year 2024 ended on March 30, 2024.

How has Transcat's net income changed over the last 2 years?

Transcat's net income appears to be on an upward trend, with a most recent value of $13.65 million in 2024, rising from $11.38 million in 2022. The previous period was $10.69 million in 2023. Check out Transcat's forecast to explore projected trends and price targets.

What is Transcat's operating income?

Transcat's total operating income in 2024 was $19.78 million, based on the following breakdown:

Total Gross Profit: $83.81 million
Total Operating Expenses: $64.03 million

How has Transcat revenue changed over the last 2 years?

Over the last 2 years, Transcat's total revenue changed from $204.96 million in 2022 to $259.48 million in 2024, a change of 26.6%.

How much debt does Transcat have?

Transcat's total liabilities were at $62.38 million at the end of 2024, a 35.1% decrease from 2023, and a 31.9% decrease since 2022.

How much cash does Transcat have?

In the past 2 years, Transcat's cash and equivalents has ranged from $1.40 million in 2022 to $19.65 million in 2024, and is currently $19.65 million as of their latest financial filing in 2024.

How has Transcat's book value per share changed over the last 2 years?

Over the last 2 years, Transcat's book value per share changed from 11.46 in 2022 to 25.50 in 2024, a change of 122.6%.

Related Companies

This page (NASDAQ:TRNS) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Transcat (TRNS) Financials

Frequently Asked Questions About Transcat's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Transcat (TRNS) Financials

Annual Income Statements for Transcat

Quarterly Income Statements for Transcat

Annual Cash Flow Statements for Transcat

Quarterly Cash Flow Statements for Transcat

Annual Balance Sheets for Transcat

Quarterly Balance Sheets for Transcat

Annual Metrics And Ratios for Transcat

Quarterly Metrics And Ratios for Transcat

Frequently Asked Questions About Transcat's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools